The Alzheimer’s therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia

Journal:

Nature Neuroscience

Published:

2025-11-24

DOI:

10.1038/s41593-025-02125-8

Affiliations:

8

Authors:

18

Go to article

Institutions	Authors	Share
Catholic University of Leuven (KU Leuven), Belgium	8.750000	0.49
Flanders Institute for Biotechnology (VIB), Belgium	8.250000	0.46
UK DRI at UCL (UK DRI UCL), United Kingdom (UK)	0.500000	0.03
VIB-UAntwerp Center for Molecular Neurology, Belgium	0.250000	0.01
University of Antwerp (UA), Belgium	0.250000	0.01

Interested in Neurosciences?